Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Douglas L. Boggs, PharmD, MS
PCC
Letter to the Editor
Substance Use and Cannabis Withdrawal
September 1, 2016
Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...
Maju Mathew Koola
,
Deanna L. Kelly
,
Robert P. McMahon
, et al
PCC
Letter to the Editor
Treatment of Hyperprolactinemia and Gynecomastia With Adjunctive Aripiprazole in 2 Men Receiving Long-Acting Injectable Antipsychotics
July 18, 2013
Douglas L. Boggs
,
Mohini Ranganathan
,
Angela A. Boggs
, et al
JCP
Original Research
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia
April 7, 2009
Deanna L. Kelly
,
Robert W. Buchanan
,
Douglas L. Boggs
, et al
